zh-twzhen
zh-twzhen

NEWS

合一生技股份有限公司 / 2025 / Oneness Biotech Co., Ltd., has been granted the Brazil Good Manufacturing Practice (B-GMP) certification for Bonvadis from Brazil ANVISA.

Oneness Biotech Co., Ltd., has been granted the Brazil Good Manufacturing Practice (B-GMP) certification for Bonvadis from Brazil ANVISA.

2025-03-25

Published Date:2025-03-25

Original Link:https://www.onenessbio.com/en/news_detail345_2.htm

No 1 Date of announcement 2025/03/25 Time of announcement  20:52:20
Subject Oneness Biotech Co., Ltd., has been granted the Brazil Good Manufacturing Practice (B-GMP) certification for Bonvadis from Brazil ANVISA.
To which item it meets Subparagraph 53 Date of events  2025/03/25
Statement
  1. Date of occurrence of the event: 2025/03/25
  2. Company Name: Oneness Biotech Co., Ltd.
  3. Relationship with the Company (Please enter the Head office or Subsidiary): Head office
  4. Mutual shareholding: Not applicable
  5. Current development stage: 
    Oneness received the notification today from the agent that Bonvadis Topical Cream has passed the Brazilian Good Manufacturing Practice (B-GMP) certification according to the Brazilian Official Announcement (DOU) issued by ANVISA.
  6. Action taken: None
  7.  Any other matters that need to be specified: The Brazilian Good Manufacturing Practice (B-GMP) certification is a mandatory regulatory requirement for approving medical device certification in Brazil. With the B-GMP certification, Oneness is eligible to apply for medical device product registration in the Brazilian market.